(CRVS) Corvus Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Corvus Pharmaceuticals | (CRVS) share price targets
Complete technical analysis of Corvus Pharmaceuticals (CRVS) by charts plus indicators, forecast predictions and share price targets for Corvus Pharmaceuticals (CRVS)
Corvus Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-08-26 View latest technical analysis
10 day averaged volume of Corvus Pharmaceuticals is 401530
| Date | Daily Closing Price | Open | High | Low | Volume |
| 26 Mon Aug 2024 | 4.13 | 4.30 | 4.35 | 3.87 | 0.838 times |
| 23 Fri Aug 2024 | 4.30 | 4.20 | 4.30 | 4.05 | 0.576 times |
| 22 Thu Aug 2024 | 4.15 | 4.13 | 4.25 | 4.11 | 0.498 times |
| 21 Wed Aug 2024 | 4.15 | 4.22 | 4.27 | 4.12 | 0.596 times |
| 20 Tue Aug 2024 | 4.20 | 4.25 | 4.30 | 4.05 | 1.637 times |
| 19 Mon Aug 2024 | 4.23 | 3.97 | 4.24 | 3.96 | 1.196 times |
| 16 Fri Aug 2024 | 4.10 | 3.72 | 4.10 | 3.60 | 1.221 times |
| 15 Thu Aug 2024 | 3.80 | 3.52 | 3.85 | 3.50 | 0.732 times |
| 14 Wed Aug 2024 | 3.49 | 3.74 | 3.80 | 3.46 | 0.817 times |
| 13 Tue Aug 2024 | 3.76 | 3.69 | 3.90 | 3.66 | 1.396 times |
My analysis of stock is bullish for shortterm, but stock is in semi over bought zones and there are some chances of seeing a fall tomorrow. Use 4.2 as stoploss in an intra day sell trade for a target of 3.59. However, stock will show a bullish move above 4.2.
Share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Target | 1.30 |
| Downside Target | 1.43 |
| Downside Target | 1.75 |
| Downside Target | 1.94 |
| Downside Target | 2.28 |
| Downside Target | 2.35 |
| Downside Target | 2.42 |
| Downside Target | 2.47 |
| Downside Target | 2.62 |
| Downside Target | 3.00 |
| Downside Target | 3.15 |
| Downside Target | 3.46 |
| Downside Target | 3.87 |
| Downside Target | 3.96 |
| Downside Target | 4.04 |
| Upside Target | 4.30 |
| Upside Target | 4.35 |
Intraday share price targets for Corvus Pharmaceuticals (CRVS)
| Target Type | Value |
| Downside Intraday Target | 3.88 |
| Downside Intraday Target | 3.64 |
| Upside Intraday Target | 4.36 |
| Upside Intraday Target | 4.6 |
| Downside Intraday Target | 4.12 |
Weekly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 26 Mon Aug 2024 | 4.13 | 4.30 | 4.35 | 3.87 | 0.186 times |
| 23 Fri Aug 2024 | 4.30 | 3.97 | 4.30 | 3.96 | 0.819 times |
| 16 Fri Aug 2024 | 4.10 | 4.00 | 4.10 | 3.46 | 0.712 times |
| 09 Fri Aug 2024 | 3.97 | 2.74 | 4.04 | 2.62 | 1.447 times |
| 02 Fri Aug 2024 | 2.98 | 2.57 | 3.15 | 2.42 | 2.711 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Corvus Pharmaceuticals (CRVS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 26 Mon Aug 2024 | 4.13 | 2.74 | 4.35 | 2.47 | 2.464 times |
| 31 Wed Jul 2024 | 2.57 | 1.81 | 3.00 | 1.75 | 1.015 times |
| 28 Fri Jun 2024 | 1.82 | 2.15 | 2.28 | 1.78 | 0.456 times |
| 31 Fri May 2024 | 2.16 | 1.53 | 2.35 | 1.43 | 2.406 times |
Scroll below to view daily charts
Price has moved up this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Corvus Pharmaceuticals (CRVS)
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
Corvus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.03 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a short to mid term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
Price action analysis of Corvus Pharmaceuticals ( (CRVS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Corvus Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Corvus Pharmaceuticals in short term and the buy signal is strong.
Corvus Pharmaceuticals Stock is trading near its recent HIGHS, which reflects strong buying momentum in short term! Bulls are getting tired and bears are picking up momentum.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Corvus Pharmaceuticals in short term but SELL signal is weak.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Corvus Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 4.03 and Corvus Pharmaceuticals (CRVS) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Corvus Pharmaceuticals (CRVS) stock. Volume based technical analysis of Corvus Pharmaceuticals (CRVS) stock is negative.
Corvus Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.